ST GERMAIN D J CO INC
Position in BCLI — Brainstorm Cell Therapeutics Inc.
CIK 831571
SPRINGFIELD, MA
Position in BCLI
as of Sep 30, 2025
· filed Oct 7, 2025
Position Value
$0
-$36 QoQ
Shares Held
33
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ST GERMAIN D J CO INC holds $2,837,885 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,834 | $2,358,269 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
3,500 | $120,120 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
14,133 | $96,245 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
1,000 | $86,950 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
324 | $78,074 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
148 | $73,516 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
75 | $23,706 | |
| 8 | MRNA |
Moderna, Inc.
|
10 | $700 |
All Filings in BCLI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 | — | 33 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $36 | 33 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $41 | 33 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $74 | 33 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $115 | 500 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $170 | 500 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $280 | 500 | Shares | Sole | 2024-04-02 | |
| 2023-12-31 | $135 | 500 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $100 | 500 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,030 | 500 | Shares | Sole | 2023-09-07 | |
| No filing history on record for this holder in this stock. | ||||||